Erythrocyte invasion and functionally inhibitory antibodies in Plasmodium falciparum malaria

Acta Tropica

Volumn 114, Issue 3, 2010, Pages 138-143

  Persson, Kristina E M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antibodies; Immunity; Inhibition; Invasion; Malaria

Indexed keywords

ERYTHROCYTE ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; MEROZOITE SURFACE PROTEIN 1;

ANTIBODY; BIOASSAY; IMMUNITY; INHIBITION; MALARIA; MEASUREMENT METHOD; PARASITE; PROTOZOAN;

ANTIGEN BINDING; CELL INVASION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HUMAN; IMMUNITY; MALARIA FALCIPARUM; MEROZOITE; NONHUMAN; PLASMODIUM FALCIPARUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANTIBODIES, PROTOZOAN; ERYTHROCYTES; HUMANS; IMMUNOASSAY; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; VIRULENCE FACTORS;

PLASMODIUM FALCIPARUM;

EID: 77950053031     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.05.017     Document Type: Review

References (86)

1. Akpogheneta O.J., Duah N.O., Tetteh K.K., Dunyo S., Lanar D.E., Pinder M., Conway D.J. Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect. Immun. 2008, 76:1748-1755.
2. Akum A.E., Minang J.T., Kuoh A.J., Ahmadou M.J., Troye-Blomberg M. Plasmodium falciparum inhibitory capacities of paired maternal-cord sera from south-west province of Cameroon. J. Trop. Pediatr. 2005, 51:182-190.
3. Aoki S., Li J., Itagaki S., Okech B.A., Egwang T.G., Matsuoka H., Palacpac N.M., Mitamura T., Horii T. Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth. J. Biol. Chem. 2002, 277:47533-47540.
4. Baker R.P., Wijetilaka R., Urban S. Two Plasmodium rhomboid proteases preferentially cleave different adhesins implicated in all invasive stages of malaria. PLoS Pathog. 2006, 2:e113.
5. Baum J., Pinder M., Conway D.J. Erythrocyte invasion phenotypes of Plasmodium falciparum in The Gambia. Infect. Immun. 2003, 71:1856-1863.
6. Baum J., Tonkin C.J., Paul A.S., Rug M., Smith B.J., Gould S.B., Richard D., Pollard T.D., Cowman A.F. A malaria parasite formin regulates actin polymerization and localizes to the parasite-erythrocyte moving junction during invasion. Cell. Host Microbe. 2008, 3:188-198.
7. Beeson J.G., Persson K.E.M. P. falciparum or growth inhibition assay using antibodies. Methods in Malaria Research 2008, pp. 94-96. fifth ed.
8. Bei A.K., Membi C.D., Rayner J.C., Mubi M., Ngasala B., Sultan A.A., Premji Z., Duraisingh M.T. Variant merozoite protein expression is associated with erythrocyte invasion phenotypes in Plasmodium falciparum isolates from Tanzania. Mol. Biochem. Parasitol. 2007, 153:66-71.
9. Bergmann-Leitner E.S., Duncan E.H., Mullen G.E., Burge J.R., Khan F., Long C.A., Angov E., Lyon J.A. Critical evaluation of different methods for measuring the functional activity of antibodies against malaria blood stage antigens. Am. J. Trop. Med. Hyg. 2006, 75:437-442.
10. Berzins K., Perlmann H., Wahlin B., Carlsson J., Wahlgren M., Udomsangpetch R., Björkman A., Patarroyo M.E., Perlmann P. Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:1065-1069.
11. Blackman M.J., Fujioka H., Stafford W.H., Sajid M., Clough B., Fleck S.L., Aikawa M., Grainger M., Hackett F. A subtilisin-like protein in secretory organelles of Plasmodium falciparum merozoites. J. Biol. Chem. 1998, 273:23398-23409.
12. Blackman M.J., Heidrich H.G., Donachie S., McBride J.S., Holder A.A. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 1990, 172:379-382.
13. Bouharoun-Tayoun H., Attanath P., Sabchareon A., Chongsuphajaisiddhi T., Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 1990, 172:1633-1641.
14. Brown G.V., Anders R.F., Mitchell G.F., Heywood P.F. Target antigens of purified human immunoglobulins which inhibit growth of Plasmodium falciparum in vitro. Nature 1982, 297:591-593.
15. Camus D., Hadley T.J. A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites. Science 1985, 230:553-556.
16. Cheesman S., Raza A., Carter R. Mixed strain infections and strain-specific protective immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi in mice. Infect. Immun. 2006, 74:2996-3001.
17. Chitarra V., Holm I., Bentley G.A., Petres S., Longacre S. The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate. Mol. Cell 1999, 3:457-464.
18. Cohen S., Butcher G.A., Crandall R.B. Action of malarial antibody in vitro. Nature 1969, 223:368-371.
19. Cohen S., McGregor I.A., Carrington S.C. Gamma-globulin and acquired immunity to human malaria. Nature 1961, 192:733-737.
20. Coley A.M., Gupta A., Murphy V.J., Bai T., Kim H., Anders R.F., Foley M., Batchelor A.H. Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. PLoS Pathog. 2007, 3:1308-1319.
21. Cowman A.F., Crabb B.S. Invasion of red blood cells by malaria parasites. Cell 2006, 124:755-766.
22. Crewther P.E., Matthew M.L., Flegg R.H., Anders R.F. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect. Immun. 1996, 64:3310-3317.
23. Dent A., Malhotra I., Mungai P., Muchiri E., Crabb B.S., Kazura J.W., King C.L. Prenatal malaria immune experience affects acquisition of Plasmodium falciparum merozoite surface protein-1 invasion inhibitory antibodies during infancy. J. Immunol. 2006, 177:7139-7145.
24. Dent A.E., Bergmann-Leitner E.S., Wilson D.W.D.J.T., Kimmel R., Vulule J., Odada Sumba P., Beeson J.G., Angov E., Moormann A.M., Kazura J.W. Antibody-mediated growth inhibition of blood stage Plasmodium falciparum decreases with age and is associated with delayed time to infection in persons with naturally acquired immunity to malaria. PLOs ONE 2008, 3:e3557.
25. Dicko A., Diemert D.J., Sagara I., Sogoba M., Niambele M.B., Assadou M.H., Guindo O., Kamate B., Baby M., Sissoko M., Malkin E.M., Fay M.P., Thera M.A., Miura K., Dolo A., Diallo D.A., Mullen G.E., Long C.A., Saul A., Doumbo O., Miller L.H. Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians. PLoS ONE 2007, 2:e1045.
26. Dodoo D., Aikins A., Kusi K.A., Lamptey H., Remarque E., Milligan P., Bosomprah S., Chilengi R., Osei Y.D., Akanmori B.D., Theisen M. Cohort study of the association of antibody levels to AMA1, MSP1-19, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Infect. Immun. 2008, 76:1748-1755.
27. Dolan S.A., Miller L.H., Wellems T.E. Evidence for a switching mechanism in the invasion of erythrocytes by Plasmodium falciparum. J. Clin. Invest. 1990, 86:618-624.
28. Doolan D.L., Mu Y., Unal B., Sundaresh S., Hirst S., Valdez C., Randall A.D.M., Liang X., Freilich D.A., Oloo J.A., Blair P.L., Aguiar J.C., Baldi P., Davies D.H., Felgner P.L. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 2008, 8:4680-4694.
29. Druilhe P., Spertini F., Soesoe D., Corradin G., Mejia P., Singh S., Audran R., Bouzidi A., Oeuvray C., Roussilhon C. A malaria vaccine that elicits humans antibodies able to kill Plasmodium falciparum. PLoS Med. 2005, 2:e344.
30. Duraisingh M.T., Triglia T., Ralph S.A., Rayner J.C., Barnwell J.W., McFadden G.I., Cowman A.F. Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes. EMBO 2003, 22:1047-1057.
31. Edozien J.C., Gilles H.M., Udeozo I.O.K. Adult and cord-blood gamma-globulin and immunity to malaria in Nigerians. Lancet 1962, 2:951-955.
32. Egan A.F., Burghaus P., Druilhe P., Holder A.A., Riley E.M. Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite Immunol. 1999, 21:133-139.
33. Fluck C., Smith T., Beck H.P., Irion A., Betuela I., Alpers M.P., Anders R., Saul A., Genton B., Felger I. Strain-specific humoral response to a polymorphic malaria vaccine. Infect. Immun. 2004, 72:6300-6305.
34. Gaur D., Furuya T., Mu J., Jiang L.B., Su X.Z., Miller L.H. Upregulation of expression of the reticulocyte homology gene 4 in the Plasmodium falciparum clone Dd2 is associated with a switch in the erythrocyte invasion pathway. Mol. Biochem. Parasitol. 2006, 145:205-215.
35. Gaur D., Singh S., Singh S., Jiang L., Diouf A., Miller L.H. Recombinant Plasmodium falciparum reticulocyte homology protein 4 binds to erythrocytes and blocks invasion. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17789-17794.
36. Gilberger T.W., Thompson J.K., Triglia T., Good R.T., Duraisingh M.T., Cowman A.F. A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes. J. Biol. Chem. 2003, 278:14480-14486.
37. Gilson P.R., Nebl T., Vukcevic D., Moritz R.L., Sargeant T., Speed T.P., Schofield L., Crabb B.S. Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite Plasmodium falciparum. Mol. Cell. Proteomics 2006, 5:1286-1299.
38. Gilson P.R., O'Donnell R.A., Nebl T., Sanders P.R., Wickham M.E., McElwain T.F., de Koning-Ward T.F., Crabb B.S. MSP1(19) miniproteins can serve as targets for invasion inhibitory antibodies in Plasmodium falciparum provided they contain the correct domains for cell surface trafficking. Mol. Microbiol. 2008, 68:124-138.
39. Gilson P.R., Crabb B.S. Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites. Int. J. Parasitol. 2009, 39:91-96.
40. Goel V.K., Li X., Chen H., Liu S.C., Chishti A.H., Oh S.S. Band 3 is a host receptor binding merozoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:5164-5169.
41. Guevara Patino J.A., Holder A.A., McBride J.S., Blackman M.J. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J. Exp. Med. 1997, 186:1689-1699.
42. Hodder A.N., Crewther P.E., Anders R.F. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun. 2001, 69:3286-3294.
43. Israelsson E., Balogun H., Vasconcelos N.M., Beser J., Roussilhon C., Rogier C., Trape J.F., Berzins K. Antibody responses to a C-terminal fragment of the Plasmodium falciparum blood-stage antigen Pf332 in Senegalese individuals naturally primed to the parasite. Clin. Exp. Immunol. 2008, 152:64-71.
44. John C.C., O'Donnell R.A., Sumba P.O., Moormann A.M., de Koning-Ward T.F., King C.L., Kazura J.W., Crabb B.S. Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa. J. Immunol. 2004, 173:666-672.
45. Kennedy M.C., Wang J., Zhang Y., Miles A.P., Chitsaz F., Saul A., Long C.A., Miller L.H., Stowers A.W. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect. Immun. 2002, 70:6948-6960.
46. Lanzilotti R., Coetzer T.L. The 10kDa domain of human erythrocyte protein 4.1 binds the Plasmodium falciparum EBA-181 protein. Malar. J. 2005, 5:100.
47. Maier A.G., Duraisingh M.T., Reeder J.C., Patel S.S., Kazura J.W., Zimmerman P.A., Cowman A.F. Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat. Med. 2003, 9:87-92.
48. Makler M.T., Ries J.M., Williams J.A., Bancroft J.E., Piper R.C., Gibbins B.L., Hinrichs D.J. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am. J. Trop. Med. Hyg. 1993, 48:739-741.
49. Malkin E., Hu J., Li Z., Chen Z., Bi X., Reed Z., Dubovsky F., Liu J., Wang Q., Pan X., Chen T., Giersing B., Xu Y., Kang X., Gu J., Shen Q., Tucker K., Tierney E., Pan W., Long C., Cao Z. A Phase 1 trial of PfCP2.9: an AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria. Vaccine 2008, (October).
50. Malkin E., Long C.A., Stowers A.W., Zou L., Singh S., MacDonald N.J., Narum D.L., Miles A.P., Orcutt A.C., Muratova O., Moretz S.E., Zhou H., Diouf A., Fay M., Tierney E., Leese P., Mahanty S., Miller L.H., Saul A., Martin L.B. Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria. PLoS Clin. Trials 2007, 2:e12.
51. Marsh K., Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol. 2006, 28:51-60.
52. Martinelli A., Cheesman S., Hunt P., Culleton R., Raza A., Mackinnon M., Carter R. A genetic approach to the de novo identification of targets of strain-specific immunity in malaria parasites. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:814-819.
53. Mayer D.C., Kaneko O., Hudson-Taylor D.E., Reid M.E., Miller L.H. Characterization of a Plasmodium falciparum erythrocyte-binding protein paralogous to EBA-175. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:5222-5227.
54. McCallum F.J., Persson K.E.M., Mugyenyi C.K., Fowkes F.J.I., Simpson J.A., Richards J.S., Williams T.N., Marsh K., Beeson J.G. Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum. PLOs ONE 2008, 3:e3571.
55. McCoubrie J.E., Miller S.K., Sargeant T., Good R.T., Hodder A.N., Speed T.P., de Koning-Ward T.F., Crabb B.S. Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design. Infect. Immun. 2007, 75:5565-5574.
56. Miller L.H., Baruch D.I., Marsh K., Doumbo O.K. The pathogenic basis of malaria. Nature 2002, 415:673-679.
57. Mitchell G.H., Thomas A.W., Margos G., Dluzewski A.R., Bannister L.H. Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merzoites to host red blood cells. Infect. Immun. 2004, 72:154-158.
58. Moreno R., Poltl-Frank F., Stuber D., Matile H., Mutz M., Weiss N.A., Pluschke G. Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro. Infect. Immun. 2001, 69:2558-2568.
59. Nery S., Deans A.M., Mosobo M., Marsh K., Rowe J.A., Conway D.J. Expression of Plasmodium falciparum genes involved in erythrocyte invasion varies among isolates cultured directly from patients. Mol. Biochem. Parasitol. 2006, 149:208-215.
60. O'Donnell R.A., de Koning-Ward T.F., Burt R.A., Bockarie M., Reeder J.C., Cowman A.F., Crabb B.S. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. J. Exp. Med. 2001, 193:1403-1412.
61. Okenu D.M., Riley E.M., Bickle Q.D., Agomo P.U., Barbosa A., Daugherty J.R., Lanar D.E., Conway D.J. Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum. Infect. Immun. 2000, 68:5559-5566.
62. Okoyeh J.N., Pillai C.R., Chitnis C.E. Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin A. Infect. Immun. 1999, 67:5784-5791.
63. Orlandi P.A., Klotz F.W., Haynes J.D. A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2-3)Gal-sequences of glycophorin Am. J. Biol. Chem. 1992, 116:901-909.
64. Osier F.H., Fegan G., Polley S.D., Murungi L., Verra F., Tetteh K.K., Lowe B., Mwangi T., Bull P.C., Thomas A.W., Cavanagh D.R., McBride J.S., Lanar D.E., Mackinnon M.J., Conway D.J., Marsh K. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect. Immun. 2008, 76:2240-2248.
65. Pang X.L., Mitamura T., Horii T. Antibodies reactive with the N-terminal domain of Plasmodium falciparum serine repeat antigen inhibit cell proliferation by agglutinating merozoites and schizonts. Infect. Immun. 1999, 67:1821-1827.
66. Persson K.E., Lee C.T., Marsh K., Beeson J.G. Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies. J. Clin. Microbiol. 2006, 44:1665-1673.
67. Persson K.E., McCallum F.J., Reiling L., Lister N.A., Stubbs J., Cowman A.F., Marsh K., Beeson J.G. Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J. Clin. Invest. 2008, 118:342-351.
68. Pizarro J.C., Chitarra V., Verger D., Holm I., Petres S., Dartevelle S., Nato F., Longacre S., Bentley G.A. Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate. J. Mol. Biol. 2003, 328:1091-1103.
69. Preiser P.R., Jarra W., Capiod T., Snounou G. A rhoptry-protein-associated mechanism of clonal phenotypic variation in rodent malaria. Nature 1999, 398:618-622.
70. Rayner J.C., Vargas-Serrato E., Huber C.S., Galinski M.R., Barnwell J.W. A Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein (PvRBP1) defines a trypsin-resistant erythrocyte invasion pathway. J. Exp. Med. 2001, 194:1571-1581.
71. Reed M.B., Caruana S.R., Batchelor A.H., Thompson J.K., Crabb B.S., Cowman A.F. Targeted disruption of an erythrocyte binding antigen in Plasmodium falciparum is associated with a switch toward a sialic acid-independent pathway of invasion. Proc. Natl. Acad. Sci. USA. 2000, 97:7509-7514.
72. Remarque E.J., Faber B.W., Kocken C.H., Thomas A.W. Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol. 2008, 24:74-84.
73. Salvatore D., Hodder A.N., Zeng W., Brown L.E., Anders R.F., Jackson D.C. Identification of antigentically active tryptic fragments of apical membrane antigen-1 (AMA1) of Plasmodium chabaudi malaria: strategies for assembly of immunologically active peptides. Vaccine 2002, 20:3477-3484.
74. Shi Y.P., Udhayakumar V., Oloo A.J., Nahlen B.L., Lal A.A. Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites. Am. J. Trop. Med. Hyg. 1999, 60:135-141.
75. Sim B.K.L. Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175. Exp. Parasitol. 1994, 78:259-268.
76. Sim B.K.L., Chitnis C.E., Wasniovska K., Hadley T.J., Miller L.H. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 1994, 264:1941-1944.
77. Singh S., Miura K., Zhou H., Muratova O., Keegan B., Miles A., Martin L.B., Saul A.J., Miller L.H., Long C.A. Immunity to recombinant Plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity. Infect. Immun. 2006, 74:4573-4580.
78. Sjöberg K., Hosein Z., Wåhlin B., Carlsson J., Wahlgren M., Troye-Blomberg M., Berzins K., Perlmann P. Plasmodium falciparum: an invasion inhibitory human monoclonal antibody is directed against a malarial glycolipid antigen. Exp. Parasitol. 1991, 73:317-325.
79. Stubbs J., Simpson K.M., Triglia T., Plouffe D., Tonkin C.J., Duraisingh M.T., Maier A.G., Winzeler E.A., Cowman A.F. Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science 2005, 309:1384-1387.
80. Theisen M., Soe S., Oeuvray C., Thomas A.W., Vuust J., Danielsen S., Jepsen S., Druilhe P. The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect. Immun. 1998, 66:11-17.
81. Thompson J.K., Triglia T., Reed M.B., Cowman A.F. A novel ligand from Plasmodium falciparum that binds to a sialic acid-containing receptor on the surface of human erythrocytes. Mol. Microbiol. 2001, 41:47-58.
82. Tolia N.H., Enemark E.J., Sim B.K., Joshua-Tor L. Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 2005, 122:183-193.
83. Triglia T., Duraisingh M.T., Good R.T., Cowman A.F. Reticulocyte-binding protein homologue 1 is required for sialic acid-dependent invasion into human erythrocytes by Plasmodium falciparum. Mol. Microbiol. 2005, 55:162-174.
84. Triglia T., Thompson J.K., Cowman A.F. An EBA175 homologue which is transcribed but not translated in erythrocytic stages of Plasmodium falciparum. Mol. Biochem. Parasitol. 2001, 116:55-63.
85. Wahlgren M., Berzins K., Perlmann P., Persson M. Characterization of the humoral immune response in Plasmodium falciparum malaria. II. IgG subclass levels of anti-P. falciparum antibodies in different sera. Clin. Exp. Immunol. 1983, 54:135-142.
86. Wipasa J., Elliott S., Xu H., Good M.F. Immunity to asexual blood stage malaria and vaccine approaches. Immunol. Cell. Biol. 2002, 80:401-414.